Source: BioSpace

Leap Therapeutics: Leap Therapeutics Reports Second Quarter 2020 Financial Results

Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported financial results for the second quarter ended June 30, 2020.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Chris Mirabelli's photo - CEO of Leap Therapeutics


Chris Mirabelli

CEO Approval Rating


Leap Therapeutics researches, develops and commercializes monoclonal antibodies that enable immune system to identify and attack cancer cells. Read more